PortfoliosLab logoPortfoliosLab logo
CMCSA vs. MRK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CMCSA vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Comcast Corporation (CMCSA) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CMCSA achieves a -7.33% return, which is significantly lower than MRK's 10.76% return. Over the past 10 years, CMCSA has underperformed MRK with an annualized return of 1.10%, while MRK has yielded a comparatively higher 11.34% annualized return.


CMCSA

1D
-2.16%
1M
-3.19%
YTD
-7.33%
6M
-1.81%
1Y
-19.31%
3Y*
-10.02%
5Y*
-11.19%
10Y*
1.10%

MRK

1D
-2.79%
1M
3.90%
YTD
10.76%
6M
16.28%
1Y
46.78%
3Y*
4.85%
5Y*
11.88%
10Y*
11.34%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CMCSA vs. MRK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CMCSA
Comcast Corporation
-7.33%-17.35%-11.84%29.08%-28.68%-2.22%19.13%34.04%-12.71%17.45%
MRK
Merck & Co., Inc.
10.76%9.79%-6.26%1.01%49.42%1.75%-7.20%22.27%39.95%-1.49%

Correlation

The correlation between CMCSA and MRK is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Jul 7, 1988

0.28

The correlation between CMCSA and MRK shifts across timeframes, from 0.13 (3 years) to 0.28 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CMCSA:

$86.70B

MRK:

$284.03B

EPS

CMCSA:

$5.05

MRK:

$3.58

PE Ratio

CMCSA:

4.75

MRK:

32.06

PEG Ratio

CMCSA:

0.10

MRK:

0.03

PS Ratio

CMCSA:

0.71

MRK:

4.37

PB Ratio

CMCSA:

0.98

MRK:

6.19

Total Revenue (TTM)

CMCSA:

$125.28B

MRK:

$65.59B

Gross Profit (TTM)

CMCSA:

$77.26B

MRK:

$49.79B

EBITDA (TTM)

CMCSA:

$45.00B

MRK:

$22.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CMCSA vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CMCSA
CMCSA Risk / Return Rank: 1414
Overall Rank
CMCSA Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
CMCSA Sortino Ratio Rank: 1616
Sortino Ratio Rank
CMCSA Omega Ratio Rank: 1515
Omega Ratio Rank
CMCSA Calmar Ratio Rank: 1515
Calmar Ratio Rank
CMCSA Martin Ratio Rank: 1111
Martin Ratio Rank

MRK
MRK Risk / Return Rank: 8686
Overall Rank
MRK Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 8585
Sortino Ratio Rank
MRK Omega Ratio Rank: 8282
Omega Ratio Rank
MRK Calmar Ratio Rank: 8989
Calmar Ratio Rank
MRK Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CMCSA vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Comcast Corporation (CMCSA) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CMCSAMRKDifference
Sharpe ratioReturn per unit of total volatility

-2.38

Sortino ratioReturn per unit of downside risk

-3.36

Omega ratioGain probability vs. loss probability

0.90

1.31

-0.41

Calmar ratioReturn relative to maximum drawdown

-0.71

4.14

-4.84

Martin ratioReturn relative to average drawdown

-1.34

10.29

-11.63

CMCSA vs. MRK - Sharpe Ratio Comparison

The current CMCSA Sharpe Ratio is -0.66, which is lower than the MRK Sharpe Ratio of 1.72. The chart below compares the historical Sharpe Ratios of CMCSA and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CMCSA vs. MRK - Drawdown Comparison

The maximum CMCSA drawdown since its inception was -67.89%, roughly equal to the maximum MRK drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for CMCSA and MRK.


Loading charts...

Drawdown Indicators


CMCSAMRKDifference

Max Drawdown

Largest peak-to-trough decline

-67.89%

-68.61%

+0.72%

Max Drawdown (1Y)

Largest decline over 1 year

-27.34%

-11.37%

-15.97%

Max Drawdown (3Y)

Largest decline over 3 years

-39.87%

-43.44%

+3.57%

Max Drawdown (5Y)

Largest decline over 5 years

-52.11%

-43.44%

-8.67%

Max Drawdown (10Y)

Largest decline over 10 years

-52.11%

-43.44%

-8.67%

Current Drawdown

Current decline from peak

-49.11%

-7.68%

-41.43%

Average Drawdown

Average peak-to-trough decline

-24.62%

-18.83%

-5.79%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.47%

4.56%

+9.91%

Volatility

CMCSA vs. MRK - Volatility Comparison

The current volatility for Comcast Corporation (CMCSA) is 7.34%, while Merck & Co., Inc. (MRK) has a volatility of 10.04%. This indicates that CMCSA experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CMCSAMRKDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.34%

10.04%

-2.70%

Volatility (6M)

Calculated over the trailing 6-month period

24.95%

18.24%

+6.71%

Volatility (1Y)

Calculated over the trailing 1-year period

29.36%

27.34%

+2.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.99%

23.71%

+3.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.51%

22.97%

+3.54%

Dividends

CMCSA vs. MRK - Dividend Comparison

CMCSA's dividend yield for the trailing twelve months is around 12.10%, more than MRK's 3.63% yield.


PositionTTM20252024202320222021202020192018201720162015
CMCSA
Comcast Corporation
12.10%4.35%3.25%2.60%3.03%1.95%1.72%1.40%2.69%1.18%1.96%1.73%
MRK
Merck & Co., Inc.
3.63%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%

Financials

CMCSA vs. MRK - Financials Comparison

This section allows you to compare key financial metrics between Comcast Corporation and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B30.00B20222023202420252026
31.46B
16.29B
(CMCSA) Total Revenue
(MRK) Total Revenue
Values in USD except per share items

CMCSA vs. MRK - Profitability Comparison

The chart below illustrates the profitability comparison between Comcast Corporation and Merck & Co., Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

55.0%60.0%65.0%70.0%75.0%80.0%20222023202420252026
65.4%
81.9%
Portfolio components
CMCSA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Comcast Corporation reported a gross profit of 20.57B and revenue of 31.46B. Therefore, the gross margin over that period was 65.4%.

MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.

CMCSA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Comcast Corporation reported an operating income of 4.14B and revenue of 31.46B, resulting in an operating margin of 13.1%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.

CMCSA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Comcast Corporation reported a net income of 2.17B and revenue of 31.46B, resulting in a net margin of 6.9%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.


Frequently Asked Questions


CMCSA and MRK have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MRK has higher volatility (10.04%) compared to CMCSA (7.34%). In terms of maximum drawdown, CMCSA dropped -67.89% vs MRK's -68.61%.

MRK currently has the higher Sharpe Ratio (1.72 vs -0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CMCSA and MRK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer